SCHOLARSHIP ASSISTANCE
The Soozie Courter Hemophilia Scholarship Program
Tuition assistance from Pfizer Hemophilia
Patients and families in the hemophilia community face challenges that extend far beyond treatment. That's why Pfizer is committed to advancing the lives of those in the community with unique support programs and resources. Our scholarship program is one of them, and is designed to inspire deserving students living with hemophilia to achieve their educational goals.
In 2000, this scholarship program was renamed to honor Soozie Courter, a valued and respected friend of the hemophilia community who passed away in 1999.
To be eligible for the scholarship, students must have either hemophilia A or hemophilia B and be a high school senior, have a high school diploma or general education development (GED) credential, or be currently enrolled in an accredited junior college, college (as an undergraduate or graduate student), or vocational school.
For the 2013-2014 academic year, Pfizer Hemophilia will award $50,000 in scholarships to students in the hemophilia community:
- $4,000 graduate school scholarships for 5 individuals
- $2,500 undergraduate college scholarships for 12 individuals
Call the Hemophilia Hotline for more information at 1-888-999-2349.
HEM520705-01
Need help paying for your Pfizer medicines?
Pfizer RSVP may be able to help, regardless of your insurance situation. Call 1-888-327-7787 or visit
www.RSVP-program.com
You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as Medwatch where health care professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit or call 1-800-FDA-1088
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions about patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.
Marketed by Pfizer Inc.
November 2012
HEM493700-01
